Recruiting OBSERVATIONAL NCT07263490
PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients) (PRIOR)
PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients) - Investigating Matching, Biomarkers and Outcomes.
Sponsor: Copenhagen University Hospital, Hvidovre
Conditions
ART Gestational Diabetes Hypertensive Disorders of Pregnancy Intrauterine Growth Restriction (IUGR) Neonatal Morbidity Neonatal Mortality Oocyte Donation Placental Abruption Post-partum Hemorrhage (PPH) Pre-Eclampsia, Severe Pre-Eclampsia; Complicating Pregnancy Pre-Eclampsia; Mild Pre-eclampsia Pre-eclampsia or Eclampsia With Pre-existing Hypertension Preterm Labor
Updated 1 time since 2026 Last updated: Dec 1, 2025 Started: Oct 21, 2024 Primary completion: Oct 31, 2027 Completion: Jun 1, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A observational or N/A phase clinical study on ART and Gestational Diabetes, this trial is actively recruiting participants. The trial is conducted by Copenhagen University Hospital, Hvidovre and has accumulated 1 data snapshot since 2024. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
1 version recorded Recruiting
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Copenhagen University Hospital, Hvidovre
- Ferring Pharmaceuticals
- Gedeon Richter Ltd.
Data source: Copenhagen University Hospital, Hvidovre
For direct contact, visit the study record on ClinicalTrials.gov .